Uvax Bio Announces Publication of Results from Preclinical Studies of HIV Vaccine Candidates Uvax Bio-owned vaccines demonstrated significant improvement in immune response compared with current vaccine strategiesPhase 1 clinical trial sponsored by National Institutes of Health expected to...